New Frontiers in Pediatric Allogeneic Stem Cell Transplantation is an international conference focused on Pediatric Blood and Marrow Transplant. The conference is sponsored by the Pediatric Bone Marrow Transplant Consortium (PBMTC) and will be held in conjunction with the American Society for Pediatric Hematology Oncology (ASPHO) Annual Meeting in Chicago in May 2014. This collaborative effort will provide an international platform for interaction between physiians and investigators active in research and clinical application of pediatric allogeneic stm cell transplantation (AlloSCT) and other members of the pediatric hematology/oncology community. Conference sessions will address topics of high relevance to children, adolescents and young adults with both malignant and non-malignant pediatric disorders. At PBMTC-ASPHO 2014, experts in pediatric allogeneic stem cell transplantation will lead in depth reviews of acute myeloid leukemia, transplant immunology, graft versus host disease, SCT-related late effects, inherited immunodeficiency disorders, infections in immune compromised hosts and cord blood transplantation. In addition, Young Investigators will be invited to present abstracts on their latest research in pediatric SCT. PBMTC-ASPHO 2014 is the second annual presentation of this joint symposium, which had a very successful debut in 2013. The conference aims to communicate the latest research in blood and marrow transplant (BMT) to general pediatric hematology/oncology attendees and the latest in non-SCT approaches to BMT physicians. In addition to the exchange of ideas, there is a strong potential to generate discussions and collaborations that will result in new studies to strengthen each field. This meeting also offers unique opportunities to establish productive scientific dialogue with international colleagues in the fields of pediatric hematology, oncology and SCT. Finally, PBMTC-ASPHO 2014 provides an unprecedented chance to connect with fellows and junior faculty whose career interests and directions are taking shape and, thereby, better address workforce needs in the field of pediatric SCT.
New Frontiers in Pediatric Allogeneic Stem Cell Transplantation (AlloSCT) is an international conference which aims to communicate the latest research developments in blood and marrow transplant for children, adolescents and young adults. AlloSCT , now used with increasing success to treat a broad range of malignant and nonmalignant pediatric diseases, is a dynamic field in which new, often publicly funded, research findings are constantly being translated from the lab bench int clinical trials and then in rapid succession into standard clinical practice. Communicaton of latest findings and development of new research approaches are critical to application of new data in clinical practice and to further improving patient outcomes in diseases such as acute leukemia, acquired and inherited bone marrow failure states, inherited immune defects and various inherited metabolic disorders. Funding of this R13 conference proposal will greatly enhance this communication.
